US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
AU2515992A
(en)
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US5478838A
(en)
|
1991-09-06 |
1995-12-26 |
Yoshitomi Pharmaceutical Industries, Ltd. |
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
EP0710283A4
(en)
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
THE EXPRESSION OF HUMAN INTERLEUKIN-1-g (b) IN A TRANSGENIC ANIMAL
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
US5977322A
(en)
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
NZ334613A
(en)
|
1996-08-12 |
2002-02-01 |
Welfide Corp |
Pharmaceutical agents comprising Rho kinase inhibitor
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
AU740598B2
(en)
|
1997-05-07 |
2001-11-08 |
William J. Crumb |
Aplidine as an L-type calcium channel enhancer
|
WO1998056913A1
(en)
|
1997-06-13 |
1998-12-17 |
Ludwig Institute For Cancer Research |
Smad6 and uses thereof
|
HUP0003731A3
(en)
|
1997-07-01 |
2002-11-28 |
Warner Lambert Co |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
AU773012B2
(en)
|
1998-07-24 |
2004-05-13 |
Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the TGF-beta family of growth factors
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
ATE292462T1
(de)
|
1999-01-07 |
2005-04-15 |
Warner Lambert Co |
Behandlung von asthma anhand von mek-inhibitoren
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
WO2000078351A1
(fr)
|
1999-06-18 |
2000-12-28 |
Mitsubishi Pharma Corporation |
Promoteurs de l'osteogenese
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
AU6865100A
(en)
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
JP3811775B2
(ja)
|
2000-07-19 |
2006-08-23 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
4−ヨードフェニルアミノベンズヒドロキサム酸の酸素化エステル
|
DE60211317T2
(de)
|
2001-03-23 |
2007-04-12 |
Bayer Corp. |
Rho-kinase inhibitoren
|
DK1370552T3
(da)
|
2001-03-23 |
2007-05-07 |
Bayer Pharmaceuticals Corp |
Rho-kinase-inhibitorer
|
EP1385946B1
(en)
|
2001-05-01 |
2009-12-23 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
AU2002330465B2
(en)
|
2001-09-21 |
2006-07-27 |
Kyoto University |
Screening method for a reprogramming agent, reprogramming agent screened by the method, method for using the reprogramming agent, method for differentiating an undifferentiated fusion cell, and production method of cells, tissues and organs.
|
US7700572B2
(en)
|
2001-11-02 |
2010-04-20 |
Giuliani International, Ltd. |
SMAD7 inhibitors for the treatment of CNS diseases
|
DE60320933D1
(de)
|
2002-01-10 |
2008-06-26 |
Bayer Healthcare Ag |
Rho-kinase inhibitoren
|
WO2003062227A1
(en)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
MXPA04007191A
(es)
|
2002-01-23 |
2005-03-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirimidina como inhibidores de rho-quinasa.
|
DE60301953T2
(de)
|
2002-03-05 |
2006-07-27 |
Artemis Pharmaceuticals Gmbh |
Durch inzucht erzeugte von embryonalen stammzellen abgeleitete mäuse
|
AU2003218157C1
(en)
|
2002-03-13 |
2011-11-24 |
Array Biopharma, Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
WO2003082808A1
(fr)
|
2002-04-03 |
2003-10-09 |
Sumitomo Pharmaceuticals Company, Limited. |
Derives de benzamide
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
CA2503646C
(en)
|
2002-10-28 |
2011-09-27 |
Bayer Healthcare Ag |
Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
|
EP1562601A1
(en)
|
2002-11-15 |
2005-08-17 |
Warner-Lambert Company LLC |
Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
|
AU2004212490B2
(en)
|
2003-02-10 |
2008-05-15 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
CA2529752A1
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
WO2005033298A1
(ja)
|
2003-10-03 |
2005-04-14 |
Keiichi Fukuda |
幹細胞から心筋細胞を分化誘導する方法
|
KR101163800B1
(ko)
|
2003-10-15 |
2012-07-09 |
산텐 세이야꾸 가부시키가이샤 |
신규 인다졸 유도체
|
WO2005038010A2
(en)
|
2003-10-16 |
2005-04-28 |
The University Court Of The University Of Edinburgh |
Control of es cell self-renewal and lineage specification, and medium therefor
|
ES2369835T3
(es)
|
2003-11-19 |
2011-12-07 |
Array Biopharma, Inc. |
Inhibidores bicíclicos de mek y métodos de síntesis de los mismos.
|
WO2005049812A1
(en)
|
2003-11-19 |
2005-06-02 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
WO2005074643A2
(en)
|
2004-01-30 |
2005-08-18 |
Smithkline Beecham Corporation |
Benzamide compounds useful as rock inhibitors
|
US7585844B2
(en)
|
2004-04-21 |
2009-09-08 |
The University Of Chicago |
Myosin light chain kinase inhibitors and methods of use
|
KR20070083559A
(ko)
|
2004-08-13 |
2007-08-24 |
더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 |
인간 배아 줄기세포에서의 자가재생 및 분화를 위한 조성물및 방법
|
WO2006026473A2
(en)
|
2004-08-25 |
2006-03-09 |
University Of Georgia Research Foundation, Inc. |
METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS
|
WO2006088867A2
(en)
|
2005-02-15 |
2006-08-24 |
Medistem Laboratories, Incorporated |
Method for expansion of stem cells
|
EP2361905B1
(en)
|
2005-05-18 |
2013-03-06 |
Array Biopharma Inc. |
Heterocyclic Inhibitors of MEK and methods of use thereof
|
CN101313065A
(zh)
|
2005-08-01 |
2008-11-26 |
纽珀滕索有限公司 |
具有恢复的潜能的重编程序细胞的生产
|
US20080242594A1
(en)
|
2005-09-08 |
2008-10-02 |
Mckay Ronald D G |
Methods for Promoting Stem Cell Proliferation and Survival
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
EP4223769A3
(en)
|
2005-12-13 |
2023-11-01 |
Kyoto University |
Nuclear reprogramming factor
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
WO2007088651A1
(ja)
|
2006-02-01 |
2007-08-09 |
The University Of Tokyo |
TGF-βシグナル阻害剤と抗腫瘍剤の組み合せ使用
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
TW200815597A
(en)
|
2006-03-30 |
2008-04-01 |
Univ Edinburgh |
Culture medium containing kinase inhibitors, and uses thereof
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
US20070259423A1
(en)
|
2006-05-02 |
2007-11-08 |
Jon Odorico |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
WO2008005268A1
(en)
|
2006-06-30 |
2008-01-10 |
Schering Corporation |
Substituted piperidines that increase p53 activity and the uses thereof
|
EP2044056B1
(en)
|
2006-07-14 |
2012-08-22 |
Novartis AG |
Pyrimidine derivatives as alk-5 inhibitors
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
CN101563449A
(zh)
|
2006-09-22 |
2009-10-21 |
理化学研究所 |
干细胞培养基及干细胞培养方法
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
US7892830B2
(en)
|
2007-01-17 |
2011-02-22 |
Wisconsin Alumni Research Foundation |
Clonal culture of human pluripotent stem cells
|
WO2008088882A2
(en)
|
2007-01-19 |
2008-07-24 |
The J. David Gladstone Institutes |
Methods of generating cardiomyocytes
|
CA2676044C
(en)
|
2007-01-30 |
2019-10-22 |
University Of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
|
US8158415B2
(en)
|
2007-02-27 |
2012-04-17 |
Procell Therapeutics Inc. |
Combined use of cell permeable Nanog and Oct4 for increasing self-renewal and suppressing differentiation of stem cells
|
EP2131840B1
(en)
|
2007-03-07 |
2018-10-17 |
MEI Pharma, Inc. |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
AU2008242106B2
(en)
|
2007-04-18 |
2013-05-16 |
Hadasit Medical Research Services And Development Ltd. |
Stem cell-derived retinal pigment epithelial cells
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
DK3293256T3
(da)
|
2007-06-29 |
2019-08-12 |
Fujifilm Cellular Dynamics Inc |
Automatiseret fremgangsmåde og apparatur til dyrkning af embryonale stamceller
|
US20120282229A1
(en)
|
2007-08-01 |
2012-11-08 |
Christian Kannemeier |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
EP3078738B1
(en)
|
2007-08-31 |
2020-05-20 |
Whitehead Institute for Biomedical Research |
Wnt pathway stimulation in reprogramming somatic cells
|
KR101564044B1
(ko)
|
2007-10-31 |
2015-10-28 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
핵초기화 방법
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
US20110033931A1
(en)
|
2007-11-29 |
2011-02-10 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
EP2227241A1
(en)
|
2007-11-30 |
2010-09-15 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving sox2 protein
|
EP2224940A1
(en)
|
2007-11-30 |
2010-09-08 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving oct4 protein
|
JP2011516042A
(ja)
|
2008-03-17 |
2011-05-26 |
へルムホルツ・ツェントルム・ミュンヘン−ドイチェス・フォルシュングスツェントルム・ヒューア・ゲズントハイト・ウント・ウムヴェルト(ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング) |
部位特異的組み換えを用いて無ベクター誘導多能性幹(iPS)細胞を作製するベクターおよびその方法
|
EP2279243B1
(en)
|
2008-03-17 |
2016-01-06 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
CN101550406B
(zh)
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
WO2010013845A1
(en)
*
|
2008-07-30 |
2010-02-04 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
JP5390624B2
(ja)
|
2008-11-04 |
2014-01-15 |
バイアサイト インク |
幹細胞集合体懸濁液組成物、その分化方法
|
ES2779001T3
(es)
|
2008-12-03 |
2020-08-13 |
Scripps Research Inst |
Cultivos de células madre
|
KR101909847B1
(ko)
|
2008-12-17 |
2018-12-18 |
더 스크립스 리서치 인스티튜트 |
줄기 세포의 생성 및 유지
|
WO2010102267A2
(en)
|
2009-03-06 |
2010-09-10 |
Ipierian, Inc. |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
WO2010120785A2
(en)
|
2009-04-13 |
2010-10-21 |
The Regents Of The University Of California |
Methods and compositions for stem cell cultures
|
AU2010253844A1
(en)
|
2009-05-27 |
2012-02-02 |
Center Of Regenerative Medicine Of Barcelona, Spain |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
WO2010137348A1
(en)
|
2009-05-29 |
2010-12-02 |
Keio University |
Method for selecting clone of induced pluripotent stem cells
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
SG10201608797WA
(en)
|
2009-08-07 |
2016-12-29 |
Univ Kyoto |
Method of efficiently establishing induced pluripotent stem cells
|
ES2638464T3
(es)
|
2009-10-16 |
2017-10-20 |
The Scripps Research Institute |
Inducción de células pluripotentes
|
EP2494039B1
(en)
|
2009-10-31 |
2019-06-19 |
Genesis Technologies Limited |
Methods for reprogramming cells and uses thereof
|
KR101775926B1
(ko)
|
2009-11-04 |
2017-09-07 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
화학 물질을 이용한 에피솜 재프로그래밍
|
ES2779048T3
(es)
*
|
2009-11-12 |
2020-08-13 |
Technion Res & Dev Foundation |
Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado
|
EP2526189B1
(en)
|
2010-01-22 |
2016-10-12 |
Kyoto University |
Method for improving induced pluripotent stem cell generation efficiency
|
AU2011218041B2
(en)
|
2010-02-17 |
2015-12-17 |
Lineage Cell Therapeutics, Inc. |
Methods for telomere length and genomic DNA quality control analysis in pluripotent stem cells
|
EP2542669B1
(en)
|
2010-03-05 |
2015-01-21 |
Texas Heart Institute |
Ets2 and mesp1 generate cardiac progenitors from fibroblasts
|
CN105176930B
(zh)
|
2010-03-31 |
2021-05-04 |
斯克里普斯研究所 |
重编程细胞
|
JPWO2011158852A1
(ja)
|
2010-06-15 |
2013-08-19 |
国立大学法人 東京大学 |
誘導型多能性幹細胞の製造方法
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
CA2802249A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
WO2012018933A2
(en)
|
2010-08-04 |
2012-02-09 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
KR102482184B1
(ko)
|
2010-12-22 |
2022-12-28 |
페이트 세러퓨틱스, 인코포레이티드 |
단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
|
US9458131B2
(en)
*
|
2011-11-08 |
2016-10-04 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
CA2858069C
(en)
|
2011-12-08 |
2020-02-11 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
WO2013159103A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
EP2853590B1
(en)
|
2012-05-22 |
2018-11-07 |
The University of Tokyo |
Method for producing antigen-specific t cells
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
KR102460549B1
(ko)
|
2014-03-04 |
2022-10-28 |
페이트 세러퓨틱스, 인코포레이티드 |
개선된 재프로그래밍 방법 및 세포 배양 플랫폼
|
SG10202111851YA
(en)
|
2015-10-16 |
2021-12-30 |
Fate Therapeutics Inc |
Platform for the Induction & Maintenance of Ground State Pluripotency
|
WO2017079673A1
(en)
|
2015-11-04 |
2017-05-11 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|